Condition
Schistosomiasis Haematobia
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07500740Not Yet RecruitingPrimary
Nanobody-based Schistosomiasis Urine Test Kit Research
NCT04264130Phase 2CompletedPrimary
Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection
NCT00138450Completed
Urinary Schistosomiasis Infection
NCT03133832Phase 3UnknownPrimary
The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium
Showing all 4 trials